Does albuterol help with bronchitis
Pro Research Analysisby 
Searched over 200M research papers
The Efficacy of Albuterol in Treating Bronchitis
Introduction to Albuterol and Bronchitis
Albuterol is a bronchodilator commonly used to treat conditions that involve airway constriction, such as asthma. Its efficacy in treating bronchitis, particularly acute bronchitis, has been the subject of various studies. This article synthesizes research findings to determine whether albuterol is effective in managing bronchitis symptoms.
Albuterol for Acute Bronchitis
Symptom Relief and Cough Reduction
Several studies have investigated the use of albuterol in patients with acute bronchitis. One study compared albuterol with erythromycin and found that patients treated with albuterol were less likely to be coughing after 7 days of treatment compared to those treated with erythromycin (41% vs. 88%, P < .05) . Another study supported these findings, showing that patients using albuterol delivered by a metered-dose inhaler (MDI) were less likely to be coughing after 7 days compared to those using a placebo inhaler (61% vs. 91%, P = .02) . These studies suggest that albuterol can effectively reduce cough in patients with acute bronchitis.
Impact on Overall Well-being
In addition to reducing cough, albuterol has been associated with trends toward earlier improvement in cough and an improved feeling of well-being . However, no significant differences were found in the length of time before patients returned to work or resumed normal activities . This indicates that while albuterol may help alleviate some symptoms, it does not necessarily speed up overall recovery.
Albuterol for Bronchiolitis
Efficacy in Infants
The efficacy of albuterol in treating bronchiolitis, particularly in infants, has been extensively studied. A randomized, double-blind, placebo-controlled trial found no significant differences in respiratory and heart rates, clinical scores, or oxygen saturation between infants treated with nebulized or oral albuterol and those given a placebo Gadomski1994Lee1995. Another study concluded that nebulized albuterol did not significantly improve clinical outcomes in infants with bronchiolitis compared to placebo .
Hospitalized Infants
For hospitalized infants with moderate bronchiolitis, a study found that nebulized albuterol did not enhance recovery or reduce the severity of illness. There were no significant differences in oxygen saturation, time to meet discharge criteria, or length of hospital stay between the albuterol and placebo groups . This suggests that albuterol may not be beneficial for infants hospitalized with bronchiolitis.
Conclusion
The research indicates that albuterol can be effective in reducing cough and improving some symptoms in patients with acute bronchitis. However, its efficacy in treating bronchiolitis, especially in infants, appears limited. Albuterol does not significantly improve clinical outcomes or recovery times in infants with bronchiolitis. Therefore, while albuterol may be beneficial for managing acute bronchitis symptoms, its use in bronchiolitis, particularly in infants, is not recommended based on current evidence.
Sources and full results
Most relevant research papers on this topic